Listed by the USPTO as ANDERSON, REBECCA L
Tech Center 1600 • Art Units: 1626
This examiner grants 73% of resolved cases
ANDERSON, REBECCA L works in Tech Center 1600 and Art Unit 1626. The profile records 1049 resolved cases, a 73.3% allowance rate, and a median of 854 days to allowance. Interviews show a 23.7% lift in the measured allowance outcome.
The listed companies are The Regents of the University of California, Compass Pathfinder Limited, and Hangzhou Zhongmei Huadong Pharmaceutical Co. Ltd. The listed firms are WILSON SONSINI GOODRICH & ROSATI, COOLEY LLP, and ELMORE PATENT LAW GROUP, PC. The substantial case volume supports using the figures for portfolio planning. Counsel can pair the timing measure with early response scheduling and use interviews to address defined technical or claim-scope disputes.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18767505 | ARYLQUINAZOLINES | Non-Final OA | Merck Patent GmbH |
| 18569721 | TREATMENT AND PREVENTION OF DEVELOPMENTAL DISORDERS AND MENTAL DISEASES | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, |
| 18532632 | TREATMENT OF MYELOPROLIFERATIVE DISEASES AND DISORDERS WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17570997 | N-SUBSTITUTED INDOLES AND OTHER HETEROCYCLES FOR TREATING BRAIN DISORDERS | Final Rejection | The Regents of the University of California |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy73.3% of resolved applications examined by Rebecca L Anderson were allowed (1,049 resolved cases), compared with 54.9% across Art Unit 1626 over the last five years.
This examiner's interview lift is +23.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Rebecca L Anderson took 854 days on average from filing to allowance.
Rebecca L Anderson examines applications in Art Unit 1626 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
